Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2018-03-20 Regulatory Filings
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2018-03-20 English
6-K
Regulatory Filings
2018-02-28 English
Annual Report 2017
Annual Report Classification · 100% confidence The document contains detailed consolidated annual accounts, including balance sheets, notes to the financial statements, and audit-related key audit matters. It is clearly a comprehensive annual financial report rather than an announcement or a summary. Given the structure and content, it falls under the 10-K category (Annual Report). FY 2017
2018-02-28 Spanish
6-K
Regulatory Filings
2018-02-23 English
Corporate Governance Report - Grifols S.A.
Remuneration Information Classification · 100% confidence The document is explicitly titled "INFORME ANUAL SOBRE REMUNERACIONES DE LOS CONSEJEROS DE SOCIEDADES ANONIMAS COTIZADAS" (Annual Report on Remuneration of Directors of Listed Public Limited Companies) and details the remuneration policy, changes, and the process for determining it for the fiscal year ending 31/12/2017. This content directly corresponds to the disclosure requirements for executive and director compensation, which maps precisely to the definition of Remuneration Information (DEF 14A in the US context, or the Spanish equivalent IAR/Informe Anual de Remuneraciones). Although it is an 'Annual' report, the specific focus on remuneration makes DEF 14A the most accurate classification among the provided options, as 10-K is a general annual report, whereas this is a specialized report on compensation.
2018-02-23 Spanish
GRIFOLS, S.A.
Major Shareholding Notification
2018-02-07 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.